Service Corporation InternationalSCI
Recorded

Service Corporation International 2026 UBS Global Healthcare Conference

Review the key takeaways and the transcript of this earnings call.

Period 2026Duration37 minParticipants2

Transcript

Preview the first fifteen paragraphs, organized by speaker.

AJ RiceAnalyst

Okay. I think we are ready to get going in the next session here. We are very pleased to have Service Corporation International with us at the conference again this year. Aaron Foley, Senior Vice President and Treasurer of the company is with us. Aaron, thanks for doing this again.

AJ RiceAnalyst

Thanks, AJ. We are about 10 months into the year.

AJ RiceAnalyst

Maybe you can give us an assessment of the company's performance year to date. What have been the challenges? What have been the positives? What is the setup look like as we move into We will talk about next year in a minute, but maybe just give us your assessment.

Aaron FoleySVP and Treasurer

Sure. I mean, it has been somewhat of a roller coaster. We came out at the beginning of the year with an assumption of a $4.20 EPS midpoint. First quarter obviously threw us for a loop. We did not, I don't think, appreciate just how strong the first quarter 2025 flu season was, nor did we expect the first quarter 2026 to be as light as it was, and those compounded to a 6% decline in volume, which on a full year basis equates to about 1.5%-2% down. That said, we were seeing some really great trajectory in our cemetery pre-need sales, which is an aspect of our business that we are able to control and drive and help to push top line. Trust fund income was coming in strong as well. The April returns were kind of screaming, if you will.

Aaron FoleySVP and Treasurer

After that 6% down first quarter volume, we assessed what we expected the rest of the year to be. We expected essentially 3% down in the second quarter, flat to slight increase in the third, and maybe a 1% or so increase in the fourth quarter. July transpires, volume actually came in a little bit better than that 1.5% down versus the 3%. Cemetery pre-need continued strong, trust fund income continued strong as well. We had been pushing some amount of cost associated with some selling cost and selling comp type dynamics, but those were all kind of getting caught up. At the end of the day, with the trust fund income strength that we were seeing, we felt comfortable continuing pushing forth, and we still maintained that $4.20 midpoint. The third quarter obviously transpired.

Aaron FoleySVP and Treasurer

Volumes, while they weren't down too tremendously, instead of being up, let's say 50 basis points, they were down 10 basis points. So instead of having a miss to the good like we saw in the second quarter, it was a miss to the bad in the third quarter on the volume side. The cost that I would term intentional, the selling comp and the advertising type costs, which relate to our seminars to drive funeral pre-need sales, as well as the cemetery cremation memorialization initiative to really drive more cremation inventory sales on our cemetery segment. We intentionally put our shoulder behind those and drove those, but the cost continued strong on that front. We did get to see some surprises on the fuel side as well as some on the healthcare side, that we can dig into some.

Aaron FoleySVP and Treasurer

As we saw the trust returns for the quarter, they ended up negative, and that really all occurred in September. As Tom mentioned on the call, we'd expected this 1% increase in volume in the fourth quarter. October volume perspectives on October 27th or 28th when we had the call, we were actually seeing down. With those expected continued cost trends, with that lighter volume expectation looking into the fourth quarter, we just felt it was prudent to go ahead and right-size the expectations and bring forth that $4.20 midpoint down to about $4, which I kind of think about it, if you step back at the 30,000-foot level and just normalize for that volume dynamic, everything else would be just noise, and we would be back at that $4.20 perspective, but this is where we're at today.

AJ RiceAnalyst

Right. Okay. Well, thanks for that. You did call out your early read at the beginning of the quarter. I don't know whether today you have any further read of what you're seeing, because even with your fourth quarter, you need a little bit of a step up versus what you saw in the first week or two.

Aaron FoleySVP and Treasurer

Yeah, it's still too early to say, 10 days into November, what the expectation might be. We do know November ends this year on Monday or Tuesday versus a weekend day, which is actually a benefit for us, but it's still too early.

AJ RiceAnalyst

Okay. I mean, I think the historic algo for growth has been 5%-7% organic business growth plus 3%-5% capital deployment producing the 8%-12% adjusted EPS growth target. Given how things have developed this year, is that the right way to frame normalized growth still for you?

Aaron FoleySVP and Treasurer

Is that the algo? Yeah, no, I do think that that's still the normalized way to think about it.

Aaron FoleySVP and Treasurer

Some of these selling comp changes relate to our shifting from more of a variable cost, or I'm sorry, a fixed cost of about, let's say, 15% of the compensation and 85% variable to more like 30% fixed, 70% variable. That dynamic, while it doesn't necessarily change the pie of what gets paid out, it changes the accounting, because the accounting for us only lets us defer those costs that are variable cost until we provide the underlying products and services. So we're seeing an increase in cost on that front that will get comped as we look forward. I don't think that that dynamic is a systemic kind of change that's going to create volatility as we look forward.

Aaron FoleySVP and Treasurer

I just think that this year we've had some of these more unexpected costs that have popped up. Fuel, obviously, when we reported it in February, we didn't expect the Iran war to occur. That said, we are starting to see some moderation in some of those oil costs that affect our gas spend. Additionally, associated healthcare costs that we've seen. Really, we've kind of broken that down into three factors or dynamics. Two, knowable. One is kind of just the base increases, generally around 8%-10% increase in healthcare cost. We're also seeing a bit higher enrollments. Of course, again, those two are generally knowable. The component that's really kind of been a little bit higher anomalously, excuse me, and anonymously because due to HIPAA laws, we don't have a good sense.

Aaron FoleySVP and Treasurer

What's driving that are these large dollar claims, and we term large dollar claims as those above $250,000. These are going to be things like cancer treatments, cardiovascular-type events that take a lot of money to treat. For the first five months of the year, we saw one or maybe two of those come through per month. As we've looked at June through September, which we just got the September data in the latter part of October, we've seen those come in about six to nine per month. That increase, because we're self-insured, we work with actuaries to assess the incurred but not reported and accrue for those expense dynamics. Given that we see it continuing into September, that's just another dynamic we're expecting to continue into the fourth quarter.

Aaron FoleySVP and Treasurer

As we look forward to next year, I would wholly expect that those should subside. We annually incentivize our employees to take annual physicals to try to capture or catch some of these health conditions that, if caught early, can be treated a lot more easily.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

Other earnings calls that day

View calls from this day